Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The accompanying chart delineates the progression ... throughout the last 30 days. Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients.

Medtech manufacturers gathered in Amsterdam to discuss the latest innovations for managing diabetes. Here are three highlights from the first day of the conference: 1. Dexcom previews new data for ...

DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across ...

DexCom , Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM) systems for diabetes management with a market capitalization of $34.8 billion, finds itself at a critical juncture as ...

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic ... 20-year pro options trader reveals his one-line chart technique that shows when to buy and sell.